-Quinagolid%20Structural%20Formula%20V1.svg)
Quinagolide
Sign in to saveQuinagolide (, ), sold under the brand name Norprolac, is a selective dopamine D2 receptor agonist which is used to manage hyperprolactinemia. It has also been found to be effective in the treatment of breast pain. It is used in the UK, but it is not available in US.
Key facts
- Drug.image
- Quinagolide.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250px
- Drug.tradename
- Norprolac
- Drug.legal_status
- Rx-only
- Drug.routes_of_administration
- Oral
- Drug.class
- Dopamine receptor agonist
- Drug.ATC_prefix
- G02
- Drug.ATC_suffix
- CB04
- Drug.CAS_number
- 87056-78-8
- Drug.PubChem
- 55645
- Drug.ChemSpiderID
- 2343034
- Drug.DrugBank
- DB09097
- Drug.UNII
- 80Q9QWN15M
- Drug.KEGG
- D07217
- Drug.ChEMBL
- 290962
- Drug.IUPAC_name
- N,N-diethyl-N-[(3S,4aS,10aR)-6-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-3-yl]sulfamide
- Drug.C
- 20
via Wikipedia infobox
Research
251 papers- The efficacy and safety of quinagolide in hyperprolactinemia treatment: A systematic review and meta-analysis.Frontiers in endocrinology · 2023
- Quinagolide vaginal ring for reduction of endometriotic lesions: Results from the QLARITY trial.European journal of obstetrics, gynecology, and reproductive biology · 2025
- Quinagolide Treatment Reduces Invasive and Angiogenic Properties of Endometrial Mesenchymal Stromal Cells.International journal of molecular sciences · 2022
- Quinagolide--a valuable treatment option for hyperprolactinaemia.European journal of endocrinology · 2006
- Quniagolide.2006
via PubMed
Article
5 sectionsContents
- Chemistry
- Synthesis
- Manufacture
- See also
- References
Quinagolide (, ), sold under the brand name Norprolac, is a selective dopamine D2 receptor agonist which is used to manage hyperprolactinemia. It has also been found to be effective in the treatment of breast pain. It is used in the UK, but it is not available in US.
==Chemistry== Quinagolide is a racemate composed of the following two enantiomers: